Last year, Lifecore Biomedical Inc generated 86.31M USD for its biggest-performing segment, Contract development and manufacturing organization ("CDMO"). The United States made the largest contribution, accounting for 145.79M USD last year. For the latest quarter, Lifecore Biomedical Inc reported the revenue of 18.61M USD for the period ending 2026-06-30, which came from the top-performing segment, HA manufacturing. United States contributed the highest revenue, at 16.40M USD.